The Wistar Institute Welcomes Two New Board Members

The Wistar Institute Welcomes Two New Board Members

March 29, 2013

PHILADELPHIA—(March 29, 2013) – The Wistar Institute recently welcomed L. Patrick Gage, Ph.D., and William A. Slaughter to its board of trustees.

L. Patrick (Pat) Gage, Ph.D., has been a leader in the pharmaceutical and biotech industry since 1971. Gage was vice president of exploratory research (discovery research for the U.S.) at Hoffmann-La Roche, Ltd. After 18 years at Hoffman-LaRoche, he joined Genetics Institute, Inc., in 1989, serving first as the head of research and development, and then as president in 1997 after Wyeth (now Pfizer) acquired the company. In 1998, Gage was named president of Wyeth Research, taking responsibility for global pharmaceutical and vaccine research and development at Wyeth and Genetics Institute. In 2000, he was named senior vice president of science and technology for Wyeth. During his career at Roche, Genetics Institute and Wyeth, he oversaw the development of more than a dozen marketed biologics, both protein pharmaceuticals and vaccines, as well as several small molecule drugs.

Gage founded enGage Biotech Consulting in 2003 to focus on guiding the development of new biopharmaceutical products and companies. In addition to serving in an advisory capacity and on biotech company boards, he serves as chairman of Cytokinetics, Inc. and chairman of Tetraphase Pharmaceuticals. He also is a scientific advisor to Pappas Ventures and aTyr Therapeutics, and serves as chair of the scientific advisory board for biologics research at Merck & Co., Inc. Gage is also a trustee of the Marine Biological Laboratories, Woods Hole, Massachusetts.

Bill SlaughterWilliam A. Slaughter is a partner in the litigation department of Ballard Spahr LLP, a national law firm headquartered in Philadelphia.  He is the immediate past Chairman of the firm's litigation department.  His practice includes representing a diverse range of clients in insolvency and corporate reorganization matters and in commercial litigation, concentrating on the defense of public companies in securities litigation, the defense of banks and other financial institutions in lender liability cases, insurance coverage litigation, and the defense of employers in class action litigation under ERISA.  In addition to his litigation and corporate reorganization practice, Slaughter serves as Ballard Spahr's General Counsel and as a member of the executive team of the firm's management committee.  He has been a partner with the Ballard firm for more than 25 years.

 

Slaughter also serves as a managing director of the Horace W. Goldsmith Foundation, as a member of the Advisory Board of the Woodrow Wilson International Center, and as a member of the boards of directors of the Kimmel Center, Inc., and the National Constitution Center, among other organizations.

 

 

The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has long held the prestigious Cancer Center designation from the National Cancer Institute. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. The Wistar Institute: Today’s Discoveries – Tomorrow’s Cures. On the web at www.wistar.org.

 

FOR IMMEDIATE RELEASE: March 29, 2013                                                  

Contact: Staci Vernick, 215-898-3716. svernick@wistar.org

###